STANDARD BIOTOOLS INC (LAB) Stock Income Statement
NASDAQ:LAB - Nasdaq - US34385P1084 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 169.69M | 174.43M | 106.34M | 97.90M | 130.60M | |||
| Cost Of Goods | 89.87M | 90.17M | 55.89M | 60.90M | 61.20M | |||
| Gross Profit | 79.81M | 84.26M | 50.45M | 37.10M | 69.40M | |||
| Operating Expenses | 206.13M | 219.02M | 113.49M | 153.30M | 136.80M | |||
| Research and Development | 57.76M | 62.41M | 25.95M | 38.50M | 37.90M | |||
| Selling, General, and Administrative Expenses | 148.37M | 156.61M | 87.54M | 114.80M | 98.90M | |||
| Operating Income | -126.32M | -134.76M | -63.04M | -116.20M | -67.50M | |||
| Interest Income/Expense | 14.86M | 16.88M | -4.57M | -64.40M | -3.80M | |||
| Other Income/Expense | 702.00K | -5.17M | 6.96M | -12.30M | 7.60M | |||
| Non Recurring Items | -21.71M | -15.27M | -13.56M | N/A | 0.00 | |||
| Income Before Taxes | -132.47M | -138.31M | -74.20M | -192.90M | -63.70M | |||
| Income Tax | 294.00K | 573.00K | 452.00K | -2.80M | -4.40M | |||
| Net Income | -132.76M | -184.90M | -74.66M | -190.10M | -59.20M | |||
| EBITDA | -110.48M | -117.90M | -47.86M | -101.17M | -51.93M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.36 | -0.52 | -0.94 | -2.43 | -0.78 | |||
| Non GAAP EPS | -0.35 | -0.55 | -0.85 | N/A | -0.78 | |||
| Statistics | ||||||||
| Gross Profit Margin | 47.04% | 48.31% | 47.44% | 37.90% | 53.14% | |||
| Profit Margin | -78.24% | -106.00% | -70.21% | -194.18% | -45.33% | |||
| Operating Profit Margin | -74.44% | -77.25% | -59.28% | -118.69% | -51.68% | |||
All data in USD